COMPANY

Synthetix Inc. DBA Helix Chemical Supply

Synthetix Inc. DBA Helix Chemical Supply: warning letter recipient for Semaglutide, Tirzepatide, as stated by public registers.

WARNING LETTER RECIPIENT

Received an FDA warning letter naming the peptide.

SemaglutideUnapproved New Drugs/Misbranded, 2024-02-07 Regulator FDA warning letters
TirzepatideUnapproved New Drugs/Misbranded, 2024-02-07 Regulator FDA warning letters

What a register states, not an endorsement or an accusation by this site. All companies.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.